FDA Drug Application (020740) for BAYCOL by BAYER PHARMS

Back to FDA Applications sponsored by BAYER PHARMS

Application Number020740
Product Number001
FormTABLET;ORAL
Dosage0.05MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameBAYCOL
Active IngredientCERIVASTATIN SODIUM



Back to FDA Applications sponsored by BAYER PHARMS